Biotech

All Articles

Praxis epilepsy medication reduces seizures in period 2 litigation

.Praxis Preciseness Medicines has racked up yet another midphase succeed in epilepsy this year, with...

Three execs resign as Dyne messages mixed data for DMD prospect

.After escaping a scientific grip many years back, Dyne Therapeutics has disclosed brand-new stage 1...

Arrowhead fires off phase 3 information in uncommon metabolic illness in front of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its hand ahead of a prospective face-off along with Ionis, ...

Pfizer, Valneva show lyme ailment chance efficient for 2nd enhancer

.Pfizer and Valneva might possess about 2 even more years to hang around just before they produce th...

Fierce Biotech Managing Editor Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Allow's study a chat with Ayla Ellison, Fierce Biotech Managing Editor and also Michelle Benz as th...

New data show how Bayer's asundexian failed to stop movements

.Bayer put on hold the phase 3 trial for its aspect XIa inhibitor asundexian behind time in 2015 aft...

Sanofi's tolebrutinib stops working 2 of 3 late-stage MS trials

.Sanofi is still bented on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, managers ...

Galapagos' stock up as fund presents intent to shape its own development

.Galapagos is happening under additional tension from real estate investors. Having actually built a...

Cell- focused Sana scoops 1st CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of considerable leadership hirings, firings...

Allist pays Jacobio $21M, landing part in Mandarin KRAS ethnicity

.Shanghai Allist Pharmaceuticals has actually gotten on its own a starring role in China's KRAS mark...